nodes	percent_of_prediction	percent_of_DWPC	metapath
Fludrocortisone—Amcinonide—ANXA1—lung cancer	0.00642	0.236	CrCbGaD
Fludrocortisone—Oedema—Crizotinib—lung cancer	0.00302	0.00493	CcSEcCtD
Fludrocortisone—Infection—Crizotinib—lung cancer	0.003	0.0049	CcSEcCtD
Fludrocortisone—Neoplasm—Irinotecan—lung cancer	0.00296	0.00484	CcSEcCtD
Fludrocortisone—Hypertension—Pemetrexed—lung cancer	0.00292	0.00477	CcSEcCtD
Fludrocortisone—Osteoporosis—Methotrexate—lung cancer	0.00291	0.00475	CcSEcCtD
Fludrocortisone—Myalgia—Pemetrexed—lung cancer	0.00287	0.0047	CcSEcCtD
Fludrocortisone—Pancreatitis—Erlotinib—lung cancer	0.00282	0.00461	CcSEcCtD
Fludrocortisone—Fluid retention—Cisplatin—lung cancer	0.00282	0.00461	CcSEcCtD
Fludrocortisone—Fracture—Methotrexate—lung cancer	0.0028	0.00459	CcSEcCtD
Fludrocortisone—Multiple fractures—Methotrexate—lung cancer	0.0028	0.00459	CcSEcCtD
Fludrocortisone—Oedema—Pemetrexed—lung cancer	0.00276	0.00451	CcSEcCtD
Fludrocortisone—Anaphylactic shock—Pemetrexed—lung cancer	0.00276	0.00451	CcSEcCtD
Fludrocortisone—Thrombophlebitis—Irinotecan—lung cancer	0.00274	0.00449	CcSEcCtD
Fludrocortisone—Skin hyperpigmentation—Methotrexate—lung cancer	0.00274	0.00448	CcSEcCtD
Fludrocortisone—Infection—Pemetrexed—lung cancer	0.00274	0.00448	CcSEcCtD
Fludrocortisone—Infection—Gefitinib—lung cancer	0.00272	0.00445	CcSEcCtD
Fludrocortisone—Hydrocortisone—ANXA1—lung cancer	0.00271	0.0995	CrCbGaD
Fludrocortisone—Hypernatraemia—Doxorubicin—lung cancer	0.00268	0.00439	CcSEcCtD
Fludrocortisone—Injury—Irinotecan—lung cancer	0.00258	0.00422	CcSEcCtD
Fludrocortisone—Amenorrhoea—Docetaxel—lung cancer	0.00257	0.00421	CcSEcCtD
Fludrocortisone—Cardiac failure congestive—Gemcitabine—lung cancer	0.00255	0.00417	CcSEcCtD
Fludrocortisone—Muscular weakness—Vinorelbine—lung cancer	0.00254	0.00415	CcSEcCtD
Fludrocortisone—Fluid retention—Paclitaxel—lung cancer	0.00253	0.00414	CcSEcCtD
Fludrocortisone—Musculoskeletal discomfort—Pemetrexed—lung cancer	0.00251	0.0041	CcSEcCtD
Fludrocortisone—Oesophagitis—Etoposide—lung cancer	0.00249	0.00407	CcSEcCtD
Fludrocortisone—Rash maculo-papular—Etoposide—lung cancer	0.00247	0.00404	CcSEcCtD
Fludrocortisone—Anaphylactoid reaction—Irinotecan—lung cancer	0.00245	0.00401	CcSEcCtD
Fludrocortisone—Pancreatitis—Vinorelbine—lung cancer	0.00244	0.00399	CcSEcCtD
Fludrocortisone—Oesophagitis—Paclitaxel—lung cancer	0.00244	0.00399	CcSEcCtD
Fludrocortisone—Rash maculo-papular—Paclitaxel—lung cancer	0.00243	0.00396	CcSEcCtD
Fludrocortisone—Neoplasm—Paclitaxel—lung cancer	0.00241	0.00394	CcSEcCtD
Fludrocortisone—Haemoglobin—Vinblastine—lung cancer	0.00241	0.00394	CcSEcCtD
Fludrocortisone—Haemorrhage—Vinblastine—lung cancer	0.0024	0.00392	CcSEcCtD
Fludrocortisone—Anaphylactoid reaction—Gemcitabine—lung cancer	0.00239	0.00391	CcSEcCtD
Fludrocortisone—Cardiac failure congestive—Cisplatin—lung cancer	0.00238	0.00389	CcSEcCtD
Fludrocortisone—Skin hyperpigmentation—Doxorubicin—lung cancer	0.00237	0.00388	CcSEcCtD
Fludrocortisone—Hypertension—Teniposide—lung cancer	0.00236	0.00386	CcSEcCtD
Fludrocortisone—Testosterone Propionate—UGT1A1—lung cancer	0.00235	0.0862	CrCbGaD
Fludrocortisone—Haemoglobin—Topotecan—lung cancer	0.00234	0.00383	CcSEcCtD
Fludrocortisone—Haemorrhage—Topotecan—lung cancer	0.00233	0.00381	CcSEcCtD
Fludrocortisone—Haemoglobin—Erlotinib—lung cancer	0.00232	0.00379	CcSEcCtD
Fludrocortisone—Haemorrhage—Erlotinib—lung cancer	0.0023	0.00377	CcSEcCtD
Fludrocortisone—Optic neuritis—Doxorubicin—lung cancer	0.00229	0.00375	CcSEcCtD
Fludrocortisone—Thrombophlebitis—Paclitaxel—lung cancer	0.00224	0.00366	CcSEcCtD
Fludrocortisone—Oedema—Teniposide—lung cancer	0.00223	0.00365	CcSEcCtD
Fludrocortisone—Anaphylactoid reaction—Cisplatin—lung cancer	0.00223	0.00364	CcSEcCtD
Fludrocortisone—NR3C2—bronchus—lung cancer	0.00222	0.0963	CbGeAlD
Fludrocortisone—Infection—Teniposide—lung cancer	0.00222	0.00363	CcSEcCtD
Fludrocortisone—Urticaria—Pemetrexed—lung cancer	0.00219	0.00358	CcSEcCtD
Fludrocortisone—Cardiac failure congestive—Etoposide—lung cancer	0.00218	0.00356	CcSEcCtD
Fludrocortisone—Urticaria—Gefitinib—lung cancer	0.00218	0.00356	CcSEcCtD
Fludrocortisone—Asthenia—Crizotinib—lung cancer	0.00216	0.00354	CcSEcCtD
Fludrocortisone—Hyperhidrosis—Teniposide—lung cancer	0.00216	0.00353	CcSEcCtD
Fludrocortisone—Fluid retention—Docetaxel—lung cancer	0.00215	0.00351	CcSEcCtD
Fludrocortisone—Cardiac failure congestive—Paclitaxel—lung cancer	0.00214	0.00349	CcSEcCtD
Fludrocortisone—Injury—Paclitaxel—lung cancer	0.00211	0.00345	CcSEcCtD
Fludrocortisone—Oesophagitis—Docetaxel—lung cancer	0.00207	0.00338	CcSEcCtD
Fludrocortisone—Abdominal distension—Irinotecan—lung cancer	0.00207	0.00338	CcSEcCtD
Fludrocortisone—Neoplasm—Docetaxel—lung cancer	0.00204	0.00334	CcSEcCtD
Fludrocortisone—Anaphylactoid reaction—Etoposide—lung cancer	0.00204	0.00334	CcSEcCtD
Fludrocortisone—Hypersensitivity—Pemetrexed—lung cancer	0.00203	0.00332	CcSEcCtD
Fludrocortisone—Hypersensitivity—Gefitinib—lung cancer	0.00202	0.0033	CcSEcCtD
Fludrocortisone—Dexamethasone—ANXA1—lung cancer	0.00202	0.0742	CrCbGaD
Fludrocortisone—Pancreatitis—Irinotecan—lung cancer	0.00201	0.00329	CcSEcCtD
Fludrocortisone—Erythema—Erlotinib—lung cancer	0.00201	0.00328	CcSEcCtD
Fludrocortisone—Sweating increased—Irinotecan—lung cancer	0.002	0.00327	CcSEcCtD
Fludrocortisone—NR3C2—trachea—lung cancer	0.00199	0.0865	CbGeAlD
Fludrocortisone—Petechiae—Methotrexate—lung cancer	0.00198	0.00324	CcSEcCtD
Fludrocortisone—Asthenia—Pemetrexed—lung cancer	0.00198	0.00323	CcSEcCtD
Fludrocortisone—Asthenia—Gefitinib—lung cancer	0.00196	0.00321	CcSEcCtD
Fludrocortisone—Dermatitis atopic—Doxorubicin—lung cancer	0.00191	0.00312	CcSEcCtD
Fludrocortisone—Thrombophlebitis—Docetaxel—lung cancer	0.0019	0.0031	CcSEcCtD
Fludrocortisone—Vertigo—Vinblastine—lung cancer	0.00187	0.00307	CcSEcCtD
Fludrocortisone—NR3C2—cardiac atrium—lung cancer	0.00187	0.0812	CbGeAlD
Fludrocortisone—Mood swings—Paclitaxel—lung cancer	0.00183	0.003	CcSEcCtD
Fludrocortisone—Pancreatitis—Cisplatin—lung cancer	0.00183	0.00299	CcSEcCtD
Fludrocortisone—Sweating increased—Cisplatin—lung cancer	0.00182	0.00297	CcSEcCtD
Fludrocortisone—Cardiac failure congestive—Docetaxel—lung cancer	0.00181	0.00296	CcSEcCtD
Fludrocortisone—Convulsion—Vinblastine—lung cancer	0.00181	0.00296	CcSEcCtD
Fludrocortisone—Hyperglycaemia—Gemcitabine—lung cancer	0.0018	0.00295	CcSEcCtD
Fludrocortisone—Hypertension—Vinblastine—lung cancer	0.0018	0.00295	CcSEcCtD
Fludrocortisone—Urticaria—Teniposide—lung cancer	0.00177	0.0029	CcSEcCtD
Fludrocortisone—Glycosuria—Doxorubicin—lung cancer	0.00174	0.00285	CcSEcCtD
Fludrocortisone—Erythema—Vinorelbine—lung cancer	0.00173	0.00284	CcSEcCtD
Fludrocortisone—Myalgia—Topotecan—lung cancer	0.00173	0.00282	CcSEcCtD
Fludrocortisone—Petechiae—Doxorubicin—lung cancer	0.00172	0.0028	CcSEcCtD
Fludrocortisone—Muscular weakness—Paclitaxel—lung cancer	0.00171	0.00279	CcSEcCtD
Fludrocortisone—Myalgia—Erlotinib—lung cancer	0.00171	0.00279	CcSEcCtD
Fludrocortisone—Abdominal distension—Paclitaxel—lung cancer	0.00169	0.00276	CcSEcCtD
Fludrocortisone—AR—epithelium—lung cancer	0.00167	0.0724	CbGeAlD
Fludrocortisone—Sweating increased—Etoposide—lung cancer	0.00166	0.00272	CcSEcCtD
Fludrocortisone—Anaphylactic shock—Topotecan—lung cancer	0.00165	0.0027	CcSEcCtD
Fludrocortisone—Haemoglobin—Irinotecan—lung cancer	0.00165	0.0027	CcSEcCtD
Fludrocortisone—AR—bronchus—lung cancer	0.00165	0.0713	CbGeAlD
Fludrocortisone—Hypersensitivity—Teniposide—lung cancer	0.00164	0.00269	CcSEcCtD
Fludrocortisone—Infection—Topotecan—lung cancer	0.00164	0.00269	CcSEcCtD
Fludrocortisone—Haemorrhage—Irinotecan—lung cancer	0.00164	0.00269	CcSEcCtD
Fludrocortisone—Pancreatitis—Paclitaxel—lung cancer	0.00164	0.00268	CcSEcCtD
Fludrocortisone—Oedema—Erlotinib—lung cancer	0.00164	0.00268	CcSEcCtD
Fludrocortisone—Sweating increased—Paclitaxel—lung cancer	0.00163	0.00267	CcSEcCtD
Fludrocortisone—Infection—Erlotinib—lung cancer	0.00163	0.00266	CcSEcCtD
Fludrocortisone—Haemoglobin—Gemcitabine—lung cancer	0.00161	0.00263	CcSEcCtD
Fludrocortisone—Amenorrhoea—Doxorubicin—lung cancer	0.00161	0.00263	CcSEcCtD
Fludrocortisone—Asthenia—Teniposide—lung cancer	0.0016	0.00262	CcSEcCtD
Fludrocortisone—Haemorrhage—Gemcitabine—lung cancer	0.0016	0.00262	CcSEcCtD
Fludrocortisone—Hyperhidrosis—Topotecan—lung cancer	0.0016	0.00261	CcSEcCtD
Fludrocortisone—Vertigo—Vinorelbine—lung cancer	0.00156	0.00255	CcSEcCtD
Fludrocortisone—Hyperglycaemia—Paclitaxel—lung cancer	0.00151	0.00247	CcSEcCtD
Fludrocortisone—Musculoskeletal discomfort—Topotecan—lung cancer	0.00151	0.00246	CcSEcCtD
Fludrocortisone—Hypertension—Vinorelbine—lung cancer	0.0015	0.00245	CcSEcCtD
Fludrocortisone—Musculoskeletal discomfort—Erlotinib—lung cancer	0.00149	0.00244	CcSEcCtD
Fludrocortisone—Insomnia—Erlotinib—lung cancer	0.00148	0.00242	CcSEcCtD
Fludrocortisone—Myalgia—Vinorelbine—lung cancer	0.00148	0.00241	CcSEcCtD
Fludrocortisone—Ecchymosis—Methotrexate—lung cancer	0.00147	0.00241	CcSEcCtD
Fludrocortisone—Neoplasm—Methotrexate—lung cancer	0.00147	0.00241	CcSEcCtD
Fludrocortisone—NR3C1—respiratory system—lung cancer	0.00145	0.0628	CbGeAlD
Fludrocortisone—NR3C2—lung—lung cancer	0.00143	0.0621	CbGeAlD
Fludrocortisone—Anaphylactic shock—Vinorelbine—lung cancer	0.00142	0.00231	CcSEcCtD
Fludrocortisone—Infection—Vinorelbine—lung cancer	0.00141	0.0023	CcSEcCtD
Fludrocortisone—Headache—Teniposide—lung cancer	0.0014	0.00229	CcSEcCtD
Fludrocortisone—Erythema—Gemcitabine—lung cancer	0.00139	0.00228	CcSEcCtD
Fludrocortisone—AR—cardiac atrium—lung cancer	0.00139	0.0602	CbGeAlD
Fludrocortisone—Thrombophlebitis—Methotrexate—lung cancer	0.00137	0.00223	CcSEcCtD
Fludrocortisone—Diabetes mellitus—Methotrexate—lung cancer	0.00136	0.00222	CcSEcCtD
Fludrocortisone—Haemoglobin—Paclitaxel—lung cancer	0.00135	0.0022	CcSEcCtD
Fludrocortisone—Fluid retention—Doxorubicin—lung cancer	0.00134	0.00219	CcSEcCtD
Fludrocortisone—Haemorrhage—Paclitaxel—lung cancer	0.00134	0.00219	CcSEcCtD
Fludrocortisone—Urticaria—Topotecan—lung cancer	0.00131	0.00215	CcSEcCtD
Fludrocortisone—Erythema—Cisplatin—lung cancer	0.0013	0.00212	CcSEcCtD
Fludrocortisone—AR—Regulation of Androgen receptor activity—CREBBP—lung cancer	0.00129	0.00383	CbGpPWpGaD
Fludrocortisone—Oesophagitis—Doxorubicin—lung cancer	0.00129	0.00211	CcSEcCtD
Fludrocortisone—Musculoskeletal discomfort—Vinorelbine—lung cancer	0.00129	0.00211	CcSEcCtD
Fludrocortisone—NR3C1—Adipogenesis—AHR—lung cancer	0.00129	0.00381	CbGpPWpGaD
Fludrocortisone—Vertigo—Irinotecan—lung cancer	0.00128	0.0021	CcSEcCtD
Fludrocortisone—NR3C2—Gene Expression—HNRNPA2B1—lung cancer	0.00128	0.0038	CbGpPWpGaD
Fludrocortisone—Rash maculo-papular—Doxorubicin—lung cancer	0.00128	0.0021	CcSEcCtD
Fludrocortisone—Neoplasm—Doxorubicin—lung cancer	0.00128	0.00209	CcSEcCtD
Fludrocortisone—Ecchymosis—Doxorubicin—lung cancer	0.00128	0.00209	CcSEcCtD
Fludrocortisone—Hypersensitivity—Vinblastine—lung cancer	0.00125	0.00205	CcSEcCtD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—RARB—lung cancer	0.00125	0.00369	CbGpPWpGaD
Fludrocortisone—Hypertension—Irinotecan—lung cancer	0.00123	0.00202	CcSEcCtD
Fludrocortisone—Anaphylactoid reaction—Methotrexate—lung cancer	0.00122	0.002	CcSEcCtD
Fludrocortisone—Asthenia—Vinblastine—lung cancer	0.00122	0.002	CcSEcCtD
Fludrocortisone—Hypersensitivity—Topotecan—lung cancer	0.00122	0.00199	CcSEcCtD
Fludrocortisone—AR—SIDS Susceptibility Pathways—TF—lung cancer	0.00122	0.0036	CbGpPWpGaD
Fludrocortisone—AR—Nongenotropic Androgen signaling—MAPK3—lung cancer	0.00121	0.00359	CbGpPWpGaD
Fludrocortisone—NR3C1—epithelium—lung cancer	0.00121	0.0525	CbGeAlD
Fludrocortisone—Hypertension—Gemcitabine—lung cancer	0.0012	0.00197	CcSEcCtD
Fludrocortisone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—TERT—lung cancer	0.00119	0.00353	CbGpPWpGaD
Fludrocortisone—NR3C1—bronchus—lung cancer	0.00119	0.0517	CbGeAlD
Fludrocortisone—Asthenia—Topotecan—lung cancer	0.00119	0.00194	CcSEcCtD
Fludrocortisone—Myalgia—Gemcitabine—lung cancer	0.00119	0.00194	CcSEcCtD
Fludrocortisone—Thrombophlebitis—Doxorubicin—lung cancer	0.00118	0.00194	CcSEcCtD
Fludrocortisone—Diabetes mellitus—Doxorubicin—lung cancer	0.00118	0.00193	CcSEcCtD
Fludrocortisone—AR—Notch-mediated HES/HEY network—CD4—lung cancer	0.00118	0.00348	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—KHSRP—lung cancer	0.00117	0.00347	CbGpPWpGaD
Fludrocortisone—Asthenia—Erlotinib—lung cancer	0.00117	0.00192	CcSEcCtD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—ANXA1—lung cancer	0.00117	0.00347	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—FOXM1—lung cancer	0.00117	0.00345	CbGpPWpGaD
Fludrocortisone—NR3C1—Circadian Clock—HIF1A—lung cancer	0.00117	0.00345	CbGpPWpGaD
Fludrocortisone—Oedema—Irinotecan—lung cancer	0.00117	0.00191	CcSEcCtD
Fludrocortisone—Anaphylactic shock—Irinotecan—lung cancer	0.00117	0.00191	CcSEcCtD
Fludrocortisone—Erythema—Paclitaxel—lung cancer	0.00117	0.00191	CcSEcCtD
Fludrocortisone—AR—Coregulation of Androgen receptor activity—CASP8—lung cancer	0.00116	0.00344	CbGpPWpGaD
Fludrocortisone—Infection—Irinotecan—lung cancer	0.00116	0.0019	CcSEcCtD
Fludrocortisone—Clobetasol propionate—CYP1A1—lung cancer	0.00116	0.0426	CrCbGaD
Fludrocortisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—FOXO3—lung cancer	0.00115	0.00341	CbGpPWpGaD
Fludrocortisone—Vascular purpura—Doxorubicin—lung cancer	0.00115	0.00187	CcSEcCtD
Fludrocortisone—NR3C1—AP-1 transcription factor network—IL10—lung cancer	0.00114	0.00338	CbGpPWpGaD
Fludrocortisone—Haemoglobin—Docetaxel—lung cancer	0.00114	0.00187	CcSEcCtD
Fludrocortisone—Anaphylactic shock—Gemcitabine—lung cancer	0.00114	0.00186	CcSEcCtD
Fludrocortisone—Oedema—Gemcitabine—lung cancer	0.00114	0.00186	CcSEcCtD
Fludrocortisone—Haemorrhage—Docetaxel—lung cancer	0.00114	0.00186	CcSEcCtD
Fludrocortisone—Cardiac failure congestive—Doxorubicin—lung cancer	0.00113	0.00185	CcSEcCtD
Fludrocortisone—Infection—Gemcitabine—lung cancer	0.00113	0.00185	CcSEcCtD
Fludrocortisone—Hyperhidrosis—Irinotecan—lung cancer	0.00113	0.00184	CcSEcCtD
Fludrocortisone—Convulsion—Cisplatin—lung cancer	0.00113	0.00184	CcSEcCtD
Fludrocortisone—Urticaria—Vinorelbine—lung cancer	0.00112	0.00184	CcSEcCtD
Fludrocortisone—Mood swings—Methotrexate—lung cancer	0.00112	0.00183	CcSEcCtD
Fludrocortisone—AR—FOXA1 transcription factor network—JUN—lung cancer	0.00111	0.00328	CbGpPWpGaD
Fludrocortisone—Myalgia—Cisplatin—lung cancer	0.00111	0.00181	CcSEcCtD
Fludrocortisone—AR—Regulation of Androgen receptor activity—MDM2—lung cancer	0.0011	0.00325	CbGpPWpGaD
Fludrocortisone—Hyperhidrosis—Gemcitabine—lung cancer	0.0011	0.0018	CcSEcCtD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—HPGDS—lung cancer	0.00109	0.00323	CbGpPWpGaD
Fludrocortisone—Prednisolone—CYP2A6—lung cancer	0.00109	0.0399	CrCbGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—SOX2—lung cancer	0.00109	0.00321	CbGpPWpGaD
Fludrocortisone—NR3C1—trachea—lung cancer	0.00107	0.0464	CbGeAlD
Fludrocortisone—Vertigo—Etoposide—lung cancer	0.00107	0.00175	CcSEcCtD
Fludrocortisone—NR3C1—Adipogenesis—LMNA—lung cancer	0.00107	0.00316	CbGpPWpGaD
Fludrocortisone—NR3C1—FOXA2 and FOXA3 transcription factor networks—ALB—lung cancer	0.00107	0.00316	CbGpPWpGaD
Fludrocortisone—Headache—Vinblastine—lung cancer	0.00107	0.00174	CcSEcCtD
Fludrocortisone—Purpura—Doxorubicin—lung cancer	0.00106	0.00174	CcSEcCtD
Fludrocortisone—AR—lung—lung cancer	0.00106	0.046	CbGeAlD
Fludrocortisone—Anaphylactic shock—Cisplatin—lung cancer	0.00106	0.00173	CcSEcCtD
Fludrocortisone—Oedema—Cisplatin—lung cancer	0.00106	0.00173	CcSEcCtD
Fludrocortisone—Anaphylactoid reaction—Doxorubicin—lung cancer	0.00106	0.00173	CcSEcCtD
Fludrocortisone—Insomnia—Irinotecan—lung cancer	0.00106	0.00173	CcSEcCtD
Fludrocortisone—Infection—Cisplatin—lung cancer	0.00105	0.00172	CcSEcCtD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—ALDOA—lung cancer	0.00105	0.00311	CbGpPWpGaD
Fludrocortisone—Vertigo—Paclitaxel—lung cancer	0.00105	0.00171	CcSEcCtD
Fludrocortisone—Hypersensitivity—Vinorelbine—lung cancer	0.00104	0.0017	CcSEcCtD
Fludrocortisone—Headache—Topotecan—lung cancer	0.00104	0.00169	CcSEcCtD
Fludrocortisone—Musculoskeletal discomfort—Gemcitabine—lung cancer	0.00104	0.00169	CcSEcCtD
Fludrocortisone—Convulsion—Etoposide—lung cancer	0.00103	0.00169	CcSEcCtD
Fludrocortisone—Insomnia—Gemcitabine—lung cancer	0.00103	0.00168	CcSEcCtD
Fludrocortisone—Hypertension—Etoposide—lung cancer	0.00103	0.00168	CcSEcCtD
Fludrocortisone—NR3C2—Gene Expression—EIF2B5—lung cancer	0.00103	0.00304	CbGpPWpGaD
Fludrocortisone—Headache—Erlotinib—lung cancer	0.00103	0.00168	CcSEcCtD
Fludrocortisone—Hyperhidrosis—Cisplatin—lung cancer	0.00102	0.00167	CcSEcCtD
Fludrocortisone—AR—FOXA1 transcription factor network—EP300—lung cancer	0.00102	0.00303	CbGpPWpGaD
Fludrocortisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—IL10—lung cancer	0.00102	0.00301	CbGpPWpGaD
Fludrocortisone—Asthenia—Vinorelbine—lung cancer	0.00102	0.00166	CcSEcCtD
Fludrocortisone—AR—Coregulation of Androgen receptor activity—CDKN2A—lung cancer	0.00101	0.003	CbGpPWpGaD
Fludrocortisone—Convulsion—Paclitaxel—lung cancer	0.00101	0.00165	CcSEcCtD
Fludrocortisone—Affect lability—Doxorubicin—lung cancer	0.00101	0.00165	CcSEcCtD
Fludrocortisone—Hypertension—Paclitaxel—lung cancer	0.00101	0.00165	CcSEcCtD
Fludrocortisone—NR3C1—cardiac atrium—lung cancer	0.00101	0.0436	CbGeAlD
Fludrocortisone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—APC—lung cancer	0.001	0.00297	CbGpPWpGaD
Fludrocortisone—Pancreatitis—Methotrexate—lung cancer	0.001	0.00164	CcSEcCtD
Fludrocortisone—AR—Nongenotropic Androgen signaling—PIK3CA—lung cancer	0.001	0.00296	CbGpPWpGaD
Fludrocortisone—Myalgia—Paclitaxel—lung cancer	0.000993	0.00162	CcSEcCtD
Fludrocortisone—Erythema—Docetaxel—lung cancer	0.000989	0.00162	CcSEcCtD
Fludrocortisone—NR3C2—Generic Transcription Pathway—NOTCH3—lung cancer	0.000987	0.00292	CbGpPWpGaD
Fludrocortisone—NR3C1—Regulation of Androgen receptor activity—CREBBP—lung cancer	0.000982	0.00291	CbGpPWpGaD
Fludrocortisone—NR3C2—lymph node—lung cancer	0.00098	0.0425	CbGeAlD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—ANXA1—lung cancer	0.000973	0.00288	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—MMP1—lung cancer	0.000971	0.00287	CbGpPWpGaD
Fludrocortisone—Anaphylactic shock—Etoposide—lung cancer	0.000971	0.00159	CcSEcCtD
Fludrocortisone—AR—Notch-mediated HES/HEY network—EP300—lung cancer	0.000971	0.00287	CbGpPWpGaD
Fludrocortisone—Mood swings—Doxorubicin—lung cancer	0.000971	0.00159	CcSEcCtD
Fludrocortisone—Musculoskeletal discomfort—Cisplatin—lung cancer	0.000966	0.00158	CcSEcCtD
Fludrocortisone—Infection—Etoposide—lung cancer	0.000965	0.00158	CcSEcCtD
Fludrocortisone—NR3C1—AP-1 transcription factor network—HIF1A—lung cancer	0.000962	0.00285	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—STK11—lung cancer	0.000957	0.00283	CbGpPWpGaD
Fludrocortisone—AR—Regulation of Androgen receptor activity—JUN—lung cancer	0.000956	0.00283	CbGpPWpGaD
Fludrocortisone—NR3C1—Circadian Clock—CREBBP—lung cancer	0.000953	0.00282	CbGpPWpGaD
Fludrocortisone—Oedema—Paclitaxel—lung cancer	0.000952	0.00156	CcSEcCtD
Fludrocortisone—Anaphylactic shock—Paclitaxel—lung cancer	0.000952	0.00156	CcSEcCtD
Fludrocortisone—Infection—Paclitaxel—lung cancer	0.000946	0.00155	CcSEcCtD
Fludrocortisone—Hyperhidrosis—Etoposide—lung cancer	0.000939	0.00153	CcSEcCtD
Fludrocortisone—NR3C2—Generic Transcription Pathway—JUNB—lung cancer	0.000935	0.00277	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—DICER1—lung cancer	0.000929	0.00275	CbGpPWpGaD
Fludrocortisone—AR—Nongenotropic Androgen signaling—HRAS—lung cancer	0.000927	0.00274	CbGpPWpGaD
Fludrocortisone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CDH1—lung cancer	0.000924	0.00273	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—TF—lung cancer	0.000923	0.00273	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—APP—lung cancer	0.000922	0.00273	CbGpPWpGaD
Fludrocortisone—AR—Regulation of nuclear SMAD2/3 signaling—CREBBP—lung cancer	0.000922	0.00273	CbGpPWpGaD
Fludrocortisone—Hyperhidrosis—Paclitaxel—lung cancer	0.00092	0.0015	CcSEcCtD
Fludrocortisone—AR—Notch-mediated HES/HEY network—STAT3—lung cancer	0.00091	0.00269	CbGpPWpGaD
Fludrocortisone—Muscular weakness—Doxorubicin—lung cancer	0.000904	0.00148	CcSEcCtD
Fludrocortisone—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—EP300—lung cancer	0.000892	0.00264	CbGpPWpGaD
Fludrocortisone—Abdominal distension—Doxorubicin—lung cancer	0.000891	0.00146	CcSEcCtD
Fludrocortisone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP2—lung cancer	0.00089	0.00263	CbGpPWpGaD
Fludrocortisone—Headache—Vinorelbine—lung cancer	0.000887	0.00145	CcSEcCtD
Fludrocortisone—NR3C1—Transcription factor regulation in adipogenesis—IL6—lung cancer	0.000885	0.00262	CbGpPWpGaD
Fludrocortisone—AR—Regulation of Androgen receptor activity—EP300—lung cancer	0.000882	0.00261	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—JUNB—lung cancer	0.000873	0.00258	CbGpPWpGaD
Fludrocortisone—Pancreatitis—Doxorubicin—lung cancer	0.000868	0.00142	CcSEcCtD
Fludrocortisone—NR3C1—Endoderm Differentiation—APC—lung cancer	0.000868	0.00257	CbGpPWpGaD
Fludrocortisone—Musculoskeletal discomfort—Paclitaxel—lung cancer	0.000867	0.00142	CcSEcCtD
Fludrocortisone—Insomnia—Paclitaxel—lung cancer	0.000861	0.00141	CcSEcCtD
Fludrocortisone—Hypersensitivity—Irinotecan—lung cancer	0.00086	0.00141	CcSEcCtD
Fludrocortisone—AR—Regulation of Androgen receptor activity—SRC—lung cancer	0.000857	0.00254	CbGpPWpGaD
Fludrocortisone—Convulsion—Docetaxel—lung cancer	0.000857	0.0014	CcSEcCtD
Fludrocortisone—AR—Coregulation of Androgen receptor activity—CCND1—lung cancer	0.000856	0.00253	CbGpPWpGaD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—MMP1—lung cancer	0.000856	0.00253	CbGpPWpGaD
Fludrocortisone—AR—Androgen receptor signaling pathway—CREBBP—lung cancer	0.000855	0.00253	CbGpPWpGaD
Fludrocortisone—Hypertension—Docetaxel—lung cancer	0.000854	0.0014	CcSEcCtD
Fludrocortisone—AR—Androgen receptor signaling pathway—RB1—lung cancer	0.000852	0.00252	CbGpPWpGaD
Fludrocortisone—NR3C1—bone marrow—lung cancer	0.000849	0.0368	CbGeAlD
Fludrocortisone—AR—SIDS Susceptibility Pathways—AVP—lung cancer	0.000843	0.00249	CbGpPWpGaD
Fludrocortisone—Myalgia—Docetaxel—lung cancer	0.000842	0.00138	CcSEcCtD
Fludrocortisone—Asthenia—Irinotecan—lung cancer	0.000837	0.00137	CcSEcCtD
Fludrocortisone—NR3C1—Regulation of Androgen receptor activity—MDM2—lung cancer	0.000834	0.00247	CbGpPWpGaD
Fludrocortisone—Haemoglobin—Methotrexate—lung cancer	0.000823	0.00135	CcSEcCtD
Fludrocortisone—Haemorrhage—Methotrexate—lung cancer	0.000819	0.00134	CcSEcCtD
Fludrocortisone—AR—Nongenotropic Androgen signaling—AKT1—lung cancer	0.000818	0.00242	CbGpPWpGaD
Fludrocortisone—Asthenia—Gemcitabine—lung cancer	0.000816	0.00133	CcSEcCtD
Fludrocortisone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CDKN2A—lung cancer	0.000816	0.00241	CbGpPWpGaD
Fludrocortisone—Oedema—Docetaxel—lung cancer	0.000807	0.00132	CcSEcCtD
Fludrocortisone—Anaphylactic shock—Docetaxel—lung cancer	0.000807	0.00132	CcSEcCtD
Fludrocortisone—Infection—Docetaxel—lung cancer	0.000802	0.00131	CcSEcCtD
Fludrocortisone—NR3C2—Gene Expression—SKI—lung cancer	0.000802	0.00237	CbGpPWpGaD
Fludrocortisone—Hyperglycaemia—Doxorubicin—lung cancer	0.000799	0.00131	CcSEcCtD
Fludrocortisone—AR—SIDS Susceptibility Pathways—HES1—lung cancer	0.000797	0.00236	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—STK11—lung cancer	0.000793	0.00235	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—IL10—lung cancer	0.000793	0.00235	CbGpPWpGaD
Fludrocortisone—Hypersensitivity—Cisplatin—lung cancer	0.000781	0.00128	CcSEcCtD
Fludrocortisone—AR—Generic Transcription Pathway—SKI—lung cancer	0.000772	0.00228	CbGpPWpGaD
Fludrocortisone—Urticaria—Etoposide—lung cancer	0.000771	0.00126	CcSEcCtD
Fludrocortisone—NR3C1—lung—lung cancer	0.000769	0.0333	CbGeAlD
Fludrocortisone—Asthenia—Cisplatin—lung cancer	0.00076	0.00124	CcSEcCtD
Fludrocortisone—Urticaria—Paclitaxel—lung cancer	0.000756	0.00124	CcSEcCtD
Fludrocortisone—Megestrol acetate—ABCB1—lung cancer	0.000749	0.0275	CrCbGaD
Fludrocortisone—Hydrocortisone—ABCG2—lung cancer	0.000743	0.0273	CrCbGaD
Fludrocortisone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CXCL8—lung cancer	0.00074	0.00219	CbGpPWpGaD
Fludrocortisone—Musculoskeletal discomfort—Docetaxel—lung cancer	0.000735	0.0012	CcSEcCtD
Fludrocortisone—Headache—Irinotecan—lung cancer	0.000731	0.0012	CcSEcCtD
Fludrocortisone—Insomnia—Docetaxel—lung cancer	0.00073	0.00119	CcSEcCtD
Fludrocortisone—AR—Androgen receptor signaling pathway—MDM2—lung cancer	0.000726	0.00215	CbGpPWpGaD
Fludrocortisone—AR—lymph node—lung cancer	0.000726	0.0315	CbGeAlD
Fludrocortisone—NR3C1—Regulation of Androgen receptor activity—JUN—lung cancer	0.000725	0.00214	CbGpPWpGaD
Fludrocortisone—Hypersensitivity—Etoposide—lung cancer	0.000715	0.00117	CcSEcCtD
Fludrocortisone—Erythema—Methotrexate—lung cancer	0.000713	0.00116	CcSEcCtD
Fludrocortisone—Haemoglobin—Doxorubicin—lung cancer	0.000712	0.00116	CcSEcCtD
Fludrocortisone—Headache—Gemcitabine—lung cancer	0.000712	0.00116	CcSEcCtD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—POMC—lung cancer	0.000711	0.0021	CbGpPWpGaD
Fludrocortisone—Haemorrhage—Doxorubicin—lung cancer	0.000709	0.00116	CcSEcCtD
Fludrocortisone—Hypersensitivity—Paclitaxel—lung cancer	0.000701	0.00115	CcSEcCtD
Fludrocortisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—CREBBP—lung cancer	0.0007	0.00207	CbGpPWpGaD
Fludrocortisone—Asthenia—Etoposide—lung cancer	0.000697	0.00114	CcSEcCtD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—ABCB1—lung cancer	0.000695	0.00205	CbGpPWpGaD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—CREBBP—lung cancer	0.000693	0.00205	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—MMP1—lung cancer	0.000692	0.00205	CbGpPWpGaD
Fludrocortisone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CCND1—lung cancer	0.000689	0.00204	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—CDKN2A—lung cancer	0.000689	0.00204	CbGpPWpGaD
Fludrocortisone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—JUN—lung cancer	0.000688	0.00203	CbGpPWpGaD
Fludrocortisone—Asthenia—Paclitaxel—lung cancer	0.000683	0.00112	CcSEcCtD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—TYMS—lung cancer	0.000682	0.00202	CbGpPWpGaD
Fludrocortisone—AR—Regulation of nuclear SMAD2/3 signaling—JUN—lung cancer	0.000681	0.00201	CbGpPWpGaD
Fludrocortisone—Progesterone—CYP2A6—lung cancer	0.000677	0.0249	CrCbGaD
Fludrocortisone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP9—lung cancer	0.000669	0.00198	CbGpPWpGaD
Fludrocortisone—NR3C1—Regulation of Androgen receptor activity—EP300—lung cancer	0.000669	0.00198	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—EIF2B4—lung cancer	0.000669	0.00198	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—HIF1A—lung cancer	0.000668	0.00198	CbGpPWpGaD
Fludrocortisone—AR—Regulation of nuclear SMAD2/3 signaling—CDKN1A—lung cancer	0.00066	0.00195	CbGpPWpGaD
Fludrocortisone—NR3C1—Regulation of Androgen receptor activity—SRC—lung cancer	0.00065	0.00192	CbGpPWpGaD
Fludrocortisone—NR3C1—Circadian Clock—EP300—lung cancer	0.000649	0.00192	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—RARB—lung cancer	0.000644	0.0019	CbGpPWpGaD
Fludrocortisone—Vertigo—Methotrexate—lung cancer	0.00064	0.00105	CcSEcCtD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—AVP—lung cancer	0.00064	0.00189	CbGpPWpGaD
Fludrocortisone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—EP300—lung cancer	0.000634	0.00188	CbGpPWpGaD
Fludrocortisone—AR—Androgen receptor signaling pathway—CCND1—lung cancer	0.000633	0.00187	CbGpPWpGaD
Fludrocortisone—AR—Androgen receptor signaling pathway—JUN—lung cancer	0.000631	0.00187	CbGpPWpGaD
Fludrocortisone—AR—Regulation of nuclear SMAD2/3 signaling—EP300—lung cancer	0.000628	0.00186	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—NPPA—lung cancer	0.000627	0.00186	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—FASLG—lung cancer	0.000627	0.00185	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—CXCL8—lung cancer	0.000624	0.00185	CbGpPWpGaD
Fludrocortisone—AR—Generic Transcription Pathway—RARB—lung cancer	0.00062	0.00183	CbGpPWpGaD
Fludrocortisone—Dexamethasone—CYP2A6—lung cancer	0.000619	0.0228	CrCbGaD
Fludrocortisone—Convulsion—Methotrexate—lung cancer	0.000617	0.00101	CcSEcCtD
Fludrocortisone—Erythema—Doxorubicin—lung cancer	0.000617	0.00101	CcSEcCtD
Fludrocortisone—AR—Androgen receptor signaling pathway—CDKN1A—lung cancer	0.000612	0.00181	CbGpPWpGaD
Fludrocortisone—AR—Androgen receptor signaling pathway—PTEN—lung cancer	0.000611	0.00181	CbGpPWpGaD
Fludrocortisone—Headache—Etoposide—lung cancer	0.000608	0.000994	CcSEcCtD
Fludrocortisone—Myalgia—Methotrexate—lung cancer	0.000607	0.000992	CcSEcCtD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—HES1—lung cancer	0.000605	0.00179	CbGpPWpGaD
Fludrocortisone—AR—Generic Transcription Pathway—NPPA—lung cancer	0.000604	0.00179	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—IL10—lung cancer	0.000601	0.00178	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—IL2—lung cancer	0.000597	0.00176	CbGpPWpGaD
Fludrocortisone—Headache—Paclitaxel—lung cancer	0.000596	0.000975	CcSEcCtD
Fludrocortisone—AR—Gene Expression—HNRNPA2B1—lung cancer	0.000596	0.00176	CbGpPWpGaD
Fludrocortisone—Hypersensitivity—Docetaxel—lung cancer	0.000594	0.000972	CcSEcCtD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—MDM2—lung cancer	0.000588	0.00174	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—HIF1A—lung cancer	0.000587	0.00173	CbGpPWpGaD
Fludrocortisone—NR3C1—Generic Transcription Pathway—SKI—lung cancer	0.000586	0.00173	CbGpPWpGaD
Fludrocortisone—AR—Androgen receptor signaling pathway—EP300—lung cancer	0.000582	0.00172	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—CCND1—lung cancer	0.000582	0.00172	CbGpPWpGaD
Fludrocortisone—Anaphylactic shock—Methotrexate—lung cancer	0.000582	0.000951	CcSEcCtD
Fludrocortisone—NR3C1—AP-1 transcription factor network—JUN—lung cancer	0.00058	0.00172	CbGpPWpGaD
Fludrocortisone—Asthenia—Docetaxel—lung cancer	0.000579	0.000946	CcSEcCtD
Fludrocortisone—Infection—Methotrexate—lung cancer	0.000578	0.000945	CcSEcCtD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—FGFR1—lung cancer	0.000577	0.00171	CbGpPWpGaD
Fludrocortisone—Methylprednisolone—ABCB1—lung cancer	0.000573	0.0211	CrCbGaD
Fludrocortisone—Testosterone—ABCG2—lung cancer	0.000572	0.021	CrCbGaD
Fludrocortisone—Triamcinolone—PTGS2—lung cancer	0.000569	0.0209	CrCbGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—BRAF—lung cancer	0.000568	0.00168	CbGpPWpGaD
Fludrocortisone—AR—Androgen receptor signaling pathway—SRC—lung cancer	0.000566	0.00168	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—MMP9—lung cancer	0.000565	0.00167	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—CASP8—lung cancer	0.000563	0.00166	CbGpPWpGaD
Fludrocortisone—Hyperhidrosis—Methotrexate—lung cancer	0.000562	0.000919	CcSEcCtD
Fludrocortisone—NR3C1—AP-1 transcription factor network—PTEN—lung cancer	0.000561	0.00166	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—RB1—lung cancer	0.000558	0.00165	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—CDH1—lung cancer	0.000556	0.00164	CbGpPWpGaD
Fludrocortisone—Vertigo—Doxorubicin—lung cancer	0.000554	0.000906	CcSEcCtD
Fludrocortisone—Dexamethasone—ABCG2—lung cancer	0.000554	0.0204	CrCbGaD
Fludrocortisone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MYC—lung cancer	0.000553	0.00163	CbGpPWpGaD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—CXCL8—lung cancer	0.00055	0.00163	CbGpPWpGaD
Fludrocortisone—AR—Regulation of nuclear SMAD2/3 signaling—MYC—lung cancer	0.000547	0.00162	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—IL6R—lung cancer	0.000547	0.00162	CbGpPWpGaD
Fludrocortisone—AR—Androgen receptor signaling pathway—STAT3—lung cancer	0.000546	0.00162	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—CREBBP—lung cancer	0.000546	0.00161	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—KHSRP—lung cancer	0.000545	0.00161	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—HSPB1—lung cancer	0.000539	0.0016	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—EP300—lung cancer	0.000535	0.00158	CbGpPWpGaD
Fludrocortisone—Convulsion—Doxorubicin—lung cancer	0.000535	0.000874	CcSEcCtD
Fludrocortisone—Hypertension—Doxorubicin—lung cancer	0.000533	0.000871	CcSEcCtD
Fludrocortisone—Musculoskeletal discomfort—Methotrexate—lung cancer	0.00053	0.000866	CcSEcCtD
Fludrocortisone—Insomnia—Methotrexate—lung cancer	0.000526	0.00086	CcSEcCtD
Fludrocortisone—NR3C1—lymph node—lung cancer	0.000526	0.0228	CbGeAlD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—IL2—lung cancer	0.000526	0.00156	CbGpPWpGaD
Fludrocortisone—Myalgia—Doxorubicin—lung cancer	0.000525	0.000859	CcSEcCtD
Fludrocortisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—JUN—lung cancer	0.000516	0.00153	CbGpPWpGaD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—JUN—lung cancer	0.000511	0.00151	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—EIF2B4—lung cancer	0.000507	0.0015	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—HIF1A—lung cancer	0.000507	0.0015	CbGpPWpGaD
Fludrocortisone—Headache—Docetaxel—lung cancer	0.000505	0.000826	CcSEcCtD
Fludrocortisone—Oedema—Doxorubicin—lung cancer	0.000504	0.000823	CcSEcCtD
Fludrocortisone—Anaphylactic shock—Doxorubicin—lung cancer	0.000504	0.000823	CcSEcCtD
Fludrocortisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN1A—lung cancer	0.000501	0.00148	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—APC—lung cancer	0.000501	0.00148	CbGpPWpGaD
Fludrocortisone—Infection—Doxorubicin—lung cancer	0.0005	0.000818	CcSEcCtD
Fludrocortisone—NR3C2—Generic Transcription Pathway—CREBBP—lung cancer	0.000497	0.00147	CbGpPWpGaD
Fludrocortisone—AR—Androgen receptor signaling pathway—EGFR—lung cancer	0.000496	0.00147	CbGpPWpGaD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—CDKN1A—lung cancer	0.000496	0.00147	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—EGF—lung cancer	0.000495	0.00146	CbGpPWpGaD
Fludrocortisone—Hyperhidrosis—Doxorubicin—lung cancer	0.000487	0.000796	CcSEcCtD
Fludrocortisone—NR3C1—Adipogenesis—RB1—lung cancer	0.000477	0.00141	CbGpPWpGaD
Fludrocortisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—EP300—lung cancer	0.000476	0.00141	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—EIF2B5—lung cancer	0.000476	0.00141	CbGpPWpGaD
Fludrocortisone—AR—Coregulation of Androgen receptor activity—AKT1—lung cancer	0.000476	0.00141	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—MDM2—lung cancer	0.000476	0.00141	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—NOTCH3—lung cancer	0.000475	0.00141	CbGpPWpGaD
Fludrocortisone—Progesterone—CYP1A1—lung cancer	0.000474	0.0174	CrCbGaD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—EP300—lung cancer	0.000472	0.0014	CbGpPWpGaD
Fludrocortisone—NR3C1—Generic Transcription Pathway—RARB—lung cancer	0.000471	0.00139	CbGpPWpGaD
Fludrocortisone—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—lung cancer	0.000469	0.00139	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—MYC—lung cancer	0.000467	0.00138	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—CASP8—lung cancer	0.000466	0.00138	CbGpPWpGaD
Fludrocortisone—Betamethasone—PTGS2—lung cancer	0.000466	0.0171	CrCbGaD
Fludrocortisone—Spironolactone—ABCB1—lung cancer	0.000465	0.0171	CrCbGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—CREBBP—lung cancer	0.000464	0.00137	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—MTOR—lung cancer	0.000463	0.00137	CbGpPWpGaD
Fludrocortisone—Urticaria—Methotrexate—lung cancer	0.000462	0.000755	CcSEcCtD
Fludrocortisone—Prednisone—ALB—lung cancer	0.00046	0.0169	CrCbGaD
Fludrocortisone—Musculoskeletal discomfort—Doxorubicin—lung cancer	0.000459	0.00075	CcSEcCtD
Fludrocortisone—NR3C1—Generic Transcription Pathway—NPPA—lung cancer	0.000459	0.00136	CbGpPWpGaD
Fludrocortisone—AR—Generic Transcription Pathway—NOTCH3—lung cancer	0.000458	0.00135	CbGpPWpGaD
Fludrocortisone—Insomnia—Doxorubicin—lung cancer	0.000455	0.000745	CcSEcCtD
Fludrocortisone—NR3C1—Gene Expression—HNRNPA2B1—lung cancer	0.000452	0.00134	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—JUNB—lung cancer	0.00045	0.00133	CbGpPWpGaD
Fludrocortisone—Testosterone—CYP1A1—lung cancer	0.000448	0.0165	CrCbGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—MAP2K1—lung cancer	0.000443	0.00131	CbGpPWpGaD
Fludrocortisone—Dexamethasone—CYP2E1—lung cancer	0.000439	0.0162	CrCbGaD
Fludrocortisone—Prednisone—ABCB1—lung cancer	0.000439	0.0161	CrCbGaD
Fludrocortisone—AR—Generic Transcription Pathway—JUNB—lung cancer	0.000434	0.00128	CbGpPWpGaD
Fludrocortisone—Dexamethasone—CYP1A1—lung cancer	0.000434	0.0159	CrCbGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—CXCL8—lung cancer	0.000433	0.00128	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—DICER1—lung cancer	0.000431	0.00127	CbGpPWpGaD
Fludrocortisone—Methyltestosterone—ALB—lung cancer	0.00043	0.0158	CrCbGaD
Fludrocortisone—Hypersensitivity—Methotrexate—lung cancer	0.000428	0.0007	CcSEcCtD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—CASP3—lung cancer	0.000426	0.00126	CbGpPWpGaD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—MAPK3—lung cancer	0.000423	0.00125	CbGpPWpGaD
Fludrocortisone—Asthenia—Methotrexate—lung cancer	0.000417	0.000682	CcSEcCtD
Fludrocortisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—lung cancer	0.000415	0.00123	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—CASP3—lung cancer	0.000415	0.00123	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—IL6R—lung cancer	0.000415	0.00123	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—CCND1—lung cancer	0.000415	0.00123	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—CREBBP—lung cancer	0.000414	0.00122	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—JUN—lung cancer	0.000414	0.00122	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—KHSRP—lung cancer	0.000414	0.00122	CbGpPWpGaD
Fludrocortisone—Prednisolone—ABCB1—lung cancer	0.000404	0.0149	CrCbGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—JUN—lung cancer	0.000403	0.00119	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—PTEN—lung cancer	0.0004	0.00118	CbGpPWpGaD
Fludrocortisone—Urticaria—Doxorubicin—lung cancer	0.0004	0.000654	CcSEcCtD
Fludrocortisone—Betamethasone—ABCB1—lung cancer	0.000396	0.0146	CrCbGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—MDM2—lung cancer	0.000394	0.00117	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—RAF1—lung cancer	0.000393	0.00116	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—ERBB2—lung cancer	0.000389	0.00115	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—TP53—lung cancer	0.000383	0.00113	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—EP300—lung cancer	0.000382	0.00113	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—PTGS2—lung cancer	0.00038	0.00112	CbGpPWpGaD
Fludrocortisone—AR—Regulation of nuclear SMAD2/3 signaling—AKT1—lung cancer	0.000379	0.00112	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—SKI—lung cancer	0.000372	0.0011	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—EP300—lung cancer	0.000372	0.0011	CbGpPWpGaD
Fludrocortisone—Hypersensitivity—Doxorubicin—lung cancer	0.000371	0.000607	CcSEcCtD
Fludrocortisone—Headache—Methotrexate—lung cancer	0.000364	0.000596	CcSEcCtD
Fludrocortisone—NR3C1—Gene Expression—EIF2B5—lung cancer	0.000361	0.00107	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—VEGFA—lung cancer	0.000361	0.00107	CbGpPWpGaD
Fludrocortisone—Asthenia—Doxorubicin—lung cancer	0.000361	0.000591	CcSEcCtD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—CASP3—lung cancer	0.000353	0.00104	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—VEGFA—lung cancer	0.000352	0.00104	CbGpPWpGaD
Fludrocortisone—AR—Androgen receptor signaling pathway—AKT1—lung cancer	0.000352	0.00104	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—IL6—lung cancer	0.000351	0.00104	CbGpPWpGaD
Fludrocortisone—NR3C1—Generic Transcription Pathway—NOTCH3—lung cancer	0.000348	0.00103	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—CCND1—lung cancer	0.000343	0.00102	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—CDKN1A—lung cancer	0.000343	0.00101	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—JUN—lung cancer	0.000343	0.00101	CbGpPWpGaD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—TP53—lung cancer	0.000338	0.000999	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—MYC—lung cancer	0.000332	0.000983	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—CDKN1A—lung cancer	0.000332	0.000983	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—PTEN—lung cancer	0.000332	0.000981	CbGpPWpGaD
Fludrocortisone—NR3C1—Generic Transcription Pathway—JUNB—lung cancer	0.000329	0.000974	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—CXCL8—lung cancer	0.000329	0.000973	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—DICER1—lung cancer	0.000327	0.000967	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—ERCC2—lung cancer	0.000327	0.000967	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—EGFR—lung cancer	0.000325	0.000962	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—EP300—lung cancer	0.000316	0.000935	CbGpPWpGaD
Fludrocortisone—Headache—Doxorubicin—lung cancer	0.000315	0.000516	CcSEcCtD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—CASP3—lung cancer	0.000315	0.000931	CbGpPWpGaD
Fludrocortisone—Hydrocortisone—ABCB1—lung cancer	0.000309	0.0114	CrCbGaD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—IL6—lung cancer	0.000309	0.000914	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—SRC—lung cancer	0.000307	0.000909	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—KRAS—lung cancer	0.000307	0.000909	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—STAT3—lung cancer	0.000306	0.000905	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—JUN—lung cancer	0.000306	0.000904	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—VEGFA—lung cancer	0.000299	0.000886	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—RARB—lung cancer	0.000299	0.000883	CbGpPWpGaD
Fludrocortisone—NR3C2—Generic Transcription Pathway—MYC—lung cancer	0.000295	0.000872	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—NPPA—lung cancer	0.000291	0.000861	CbGpPWpGaD
Fludrocortisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—lung cancer	0.000288	0.000852	CbGpPWpGaD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—AKT1—lung cancer	0.000285	0.000843	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—MAPK3—lung cancer	0.000283	0.000838	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—SKI—lung cancer	0.000282	0.000835	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—EP300—lung cancer	0.000282	0.000834	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—MYC—lung cancer	0.000276	0.000815	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—TP53—lung cancer	0.000273	0.000808	CbGpPWpGaD
Fludrocortisone—Dexamethasone—PTGS2—lung cancer	0.000271	0.00996	CrCbGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—EGFR—lung cancer	0.000269	0.000797	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—VEGFA—lung cancer	0.000267	0.00079	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—KRAS—lung cancer	0.000255	0.000753	CbGpPWpGaD
Fludrocortisone—Progesterone—ABCB1—lung cancer	0.000252	0.00926	CrCbGaD
Fludrocortisone—AR—Gene Expression—HSPB1—lung cancer	0.00025	0.00074	CbGpPWpGaD
Fludrocortisone—Testosterone—ALB—lung cancer	0.00025	0.00918	CrCbGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—IL6—lung cancer	0.000244	0.00072	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—CREBBP—lung cancer	0.000239	0.000708	CbGpPWpGaD
Fludrocortisone—Testosterone—ABCB1—lung cancer	0.000238	0.00876	CrCbGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—PIK3CA—lung cancer	0.000234	0.000692	CbGpPWpGaD
Fludrocortisone—AR—Generic Transcription Pathway—CREBBP—lung cancer	0.000231	0.000682	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—AKT1—lung cancer	0.000231	0.000682	CbGpPWpGaD
Fludrocortisone—Dexamethasone—ABCB1—lung cancer	0.00023	0.00847	CrCbGaD
Fludrocortisone—NR3C1—Gene Expression—RARB—lung cancer	0.000227	0.00067	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—TP53—lung cancer	0.000226	0.000669	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—NPPA—lung cancer	0.000221	0.000653	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—NOTCH3—lung cancer	0.000221	0.000652	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—IL6—lung cancer	0.000214	0.000632	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—JUNB—lung cancer	0.000209	0.000618	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—AKT1—lung cancer	0.000191	0.000565	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—HSPB1—lung cancer	0.00019	0.000562	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—IL6—lung cancer	0.000185	0.000546	CbGpPWpGaD
Fludrocortisone—NR3C1—Generic Transcription Pathway—CREBBP—lung cancer	0.000175	0.000517	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—NOTCH3—lung cancer	0.000167	0.000495	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—JUNB—lung cancer	0.000158	0.000469	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—ERCC2—lung cancer	0.000152	0.000448	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—MAPK3—lung cancer	0.000146	0.000432	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—MYC—lung cancer	0.000142	0.00042	CbGpPWpGaD
Fludrocortisone—AR—Generic Transcription Pathway—MYC—lung cancer	0.000137	0.000405	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—ERCC2—lung cancer	0.000115	0.00034	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—CREBBP—lung cancer	0.000111	0.000328	CbGpPWpGaD
Fludrocortisone—NR3C1—Generic Transcription Pathway—MYC—lung cancer	0.000104	0.000307	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—AKT1—lung cancer	9.85e-05	0.000291	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—CREBBP—lung cancer	8.42e-05	0.000249	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—MAPK3—lung cancer	6.77e-05	0.0002	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—MYC—lung cancer	6.59e-05	0.000195	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—MAPK3—lung cancer	5.14e-05	0.000152	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—MYC—lung cancer	5e-05	0.000148	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—AKT1—lung cancer	4.57e-05	0.000135	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—AKT1—lung cancer	3.47e-05	0.000103	CbGpPWpGaD
